Logo

Evotec and Genedata to Co-Market Lead Discovery Instruments, Software

Sep 13, 2005

NEW YORK, Sept. 13 (GenomeWeb News) - Evotec Technologies and Genedata will co-market their screening instrumentation and drug-discovery software, the companies said today.

 

Under the agreement, the partners will jointly offer Evotec's Evoscreen and Plate Explorer high throughput screening instrumentats and Acapella data -analysis software and Genedata's Screener validation software.

 

According to the companies, combining these products will provide more detailed information about potential lead structures.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.